The Influence of the MAPK Pathway on T Cell Lineage Commitment

Slides:



Advertisements
Similar presentations
Volume 44, Issue 3, Pages (March 2016)
Advertisements

Volume 7, Issue 5, Pages (November 1997)
Volume 6, Issue 4, Pages (April 1997)
Volume 15, Issue 6, Pages (December 2001)
Volume 13, Issue 4, Pages (October 2000)
Megakaryocyte Growth and Development Factor-Induced Proliferation and Differentiation Are Regulated by the Mitogen-Activated Protein Kinase Pathway in.
Regulation of Mast Cell Survival by IgE
Volume 26, Issue 3, Pages (March 2007)
Volume 15, Issue 1, Pages (July 2001)
Volume 31, Issue 2, Pages (August 2009)
Volume 44, Issue 3, Pages (March 2016)
The Roles of Fas/APO-1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice  Huey-Kang Sytwu, Roland S Liblau, Hugh.
Volume 5, Issue 5, Pages (November 1996)
Ananda W Goldrath, Michael J Bevan  Immunity 
Local Expression of TNFα in Neonatal NOD Mice Promotes Diabetes by Enhancing Presentation of Islet Antigens  E.Allison Green, Elizabeth E. Eynon, Richard.
Thomas R Malek, Aixin Yu, Vladimir Vincek, Paul Scibelli, Lin Kong 
Highly Efficient Selection of CD4 and CD8 Lineage Thymocytes Supports an Instructive Model of Lineage Commitment  Andrea Itano, Ellen Robey  Immunity 
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Volume 87, Issue 3, Pages (November 1996)
Volume 44, Issue 3, Pages (March 2016)
Volume 15, Issue 6, Pages (December 2001)
Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu,
Volume 19, Issue 1, Pages (July 2003)
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
Unexpectedly Complex Regulation of CD4/CD8 Coreceptor Expression Supports a Revised Model for CD4+CD8+ Thymocyte Differentiation  Bruno Lucas, Ronald.
Volume 20, Issue 1, Pages (January 2004)
Fyn Can Partially Substitute for Lck in T Lymphocyte Development
Acquisition of a Functional T Cell Receptor during T Lymphocyte Development Is Enforced by HEB and E2A Transcription Factors  Mary Elizabeth Jones, Yuan.
Lck Activity Controls CD4/CD8 T Cell Lineage Commitment
Volume 20, Issue 1, Pages (January 2004)
Impaired Th2 Subset Development in the Absence of CD4
Differential Roles of ERK and p38 MAP Kinase Pathways in Positive and Negative Selection of T Lymphocytes  Takehiko Sugawara, Tetsuo Moriguchi, Eisuke.
Volume 10, Issue 3, Pages (March 1999)
Volume 23, Issue 3, Pages (September 2005)
Regulation of Mast Cell Survival by IgE
Notch1 Signaling Promotes the Maturation of CD4 and CD8 SP Thymocytes
Volume 6, Issue 6, Pages (June 1997)
Volume 9, Issue 5, Pages (November 1998)
A Role for CaMKII in T Cell Memory
Volume 25, Issue 5, Pages (November 2006)
Skint-1 Identifies a Common Molecular Mechanism for the Development of Interferon-γ- Secreting versus Interleukin-17-Secreting γδ T Cells  Gleb Turchinovich,
A Role for FADD in T Cell Activation and Development
The Fas antigen is involved in thymic T-cell development as a costimulatory molecule, but not in the deletion of neglected thymocytes  Kazuhiro Kurasawa,
Volume 15, Issue 5, Pages (November 2001)
Volume 12, Issue 5, Pages (May 2000)
Kai M Müller, Carrie J Luedecker, Mark C Udey, Andrew G Farr  Immunity 
Volume 24, Issue 1, Pages (January 2006)
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 27, Issue 3, Pages (September 2007)
Volume 28, Issue 3, Pages (March 2008)
Volume 25, Issue 4, Pages (October 2006)
Volume 17, Issue 5, Pages (November 2002)
Volume 14, Issue 1, Pages (January 2001)
Volume 7, Issue 2, Pages (August 1997)
Volume 28, Issue 5, Pages (May 2008)
CD83 Expression Influences CD4+ T Cell Development in the Thymus
Volume 7, Issue 3, Pages (September 1997)
T Cell Receptor δ Gene Rearrangement and T Early α (TEA) Expression in Immature αβ LineageThymocytes: Implications for αβ/γδ Lineage Commitment  Anne.
Notch 1 Signaling Regulates Peripheral T Cell Activation
Volume 9, Issue 3, Pages (September 1998)
Luk Van Parijs, Alexander Ibraghimov, Abul K. Abbas  Immunity 
Volume 25, Issue 1, Pages (July 2006)
Volume 27, Issue 5, Pages (November 2007)
Volume 17, Issue 1, Pages (July 2002)
Volume 23, Issue 4, Pages (October 2005)
Volume 10, Issue 2, Pages (February 1999)
The Role of Erk1 and Erk2 in Multiple Stages of T Cell Development
Activation of the Lck Tyrosine Kinase Targets Cell Surface T Cell Antigen Receptors for Lysosomal Degradation  Ugo D'Oro, Melanie S Vacchio, Allan M Weissman,
Thymocyte Glucocorticoid Resistance Alters Positive Selection and Inhibits Autoimmunity and Lymphoproliferative Disease in MRL-lpr/lprMice  Eva Tolosa,
Generation of Functional Thymocytes in the Human Adult
Presentation transcript:

The Influence of the MAPK Pathway on T Cell Lineage Commitment Leslie L Sharp, David A Schwarz, Cynthia M Bott, Christopher J Marshall, Stephen M Hedrick  Immunity  Volume 7, Issue 5, Pages 609-618 (November 1997) DOI: 10.1016/S1074-7613(00)80382-9

Figure 1 ERK2sem Is Expressed and Can be Activated in Lymphocytes (A) Representation of the pTEX-SM targeting construct used in the generation of ERKsem (SM) transgenic mice (see Experimental Procedures). (B) Cells (5 × 106) from the indicated organs were incubated at 37°C for 10 min in the presence or absence of 5 ng/mL PMA. The cells were then lysed and immunoblotted using anti-ERK2 (C-14). LN, lymph node; NLC, normal littermate control. (C) Thymocytes were stimulated with 5 ng/mL PMA in Hank's balanced salt solution at 37°C for the indicated times. Whole-cell lysate (20 μg) was immunoblotted with anti-phospho-MAPK. Immunity 1997 7, 609-618DOI: (10.1016/S1074-7613(00)80382-9)

Figure 5 MEK Inhibitor Blocks Thymocyte Proliferation and ERK Phosphorylation (A) Thymocytes from normal littermate control (NLC) mice (circles) or sem20 (SM) mice (square) were treated with varying concentrations of PMA (filled symbols) or PMA and 17.5 μM PD98059 (open symbols). Proliferation was measured after 3 days in culture by the incorporation [3H]thymidine. (B) Thymocytes were incubated at 37°C for 1 hr in the presence or absence of 30 μM PD98059 then for an additional 10 min in the presence or absence of 10 ng/mL PMA. Whole-cell lysates from 5 × 106 cells were immunoblotted with anti-ERK2 (C-14). Immunity 1997 7, 609-618DOI: (10.1016/S1074-7613(00)80382-9)

Figure 2 ERKsem Alters Thymus and Lymph Node Subsets Cells from sem20 (SM) or normal littermate control (NLC) mice were stained with anti-CD4-PE and anti-CD8-Tricolor. Numbers represent the percentage of live cells in the indicated quadrant. Ten thousand events are shown. E16 FTOC, cells after 5 days of culture starting at embryonic day 16. Immunity 1997 7, 609-618DOI: (10.1016/S1074-7613(00)80382-9)

Figure 3 Alteration of Thymic Subsets in AND × sem20 (AND × SM) Double-Transgenic Mice Is MHC Haplotype–Dependent Thymocytes were triple stained with anti-CD4-PE, anti-CD8-Tricolor, and anti-CD3-FITC. Numbers represent the percentage of cells in the indicated quadrant. Ten thousand events are shown. Dashed lines, AND normal littermate control; solid lines, AND × SM. Immunity 1997 7, 609-618DOI: (10.1016/S1074-7613(00)80382-9)

Figure 4 MEK Activation Is Required for TCR and Peptide-Mediated Proliferation (A) Lymph node cells from a sem20 (SM) mouse (filled squares) or a normal littermate control (open squares) mouse were stimulated with 10 ng/well 145–2C11 (anti-CD3) and the indicated concentration of PD98059 MEK Inhibitor. Proliferation after 3 days was determined by the incorportion of 1 μCi of [3H]thymidine. (B) AND-H-2b lymph node cells were cultured with mitomycin C–treated B10.A splenic antigen-presenting cells and the indicated concentrations of PCC peptide in the presence (open squares) or absence (filled squares) of 25 μM PD98059. Immunity 1997 7, 609-618DOI: (10.1016/S1074-7613(00)80382-9)

Figure 6 ERK Is Not Required for Transition to CD8 SP E14 thymi were cultured for 5 days in the presence or absence of 30 μM PD98059 MEK inhibitor. Thymocytes were triple stained with anti-CD4-PE, anti-CD8-Tricolor, and anti-CD3-FITC. Numbers represent the percentage of live cells in the indicated quadrant. Histograms represent CD3 expression of total or SP thymocytes. Dashed lines, thymi cultured in medium alone; solid lines, thymi cultured with 30 μM PD98059. The average cell recovery (× 10−5) was 6.7 ± 0.6 for controls (n = 7) and 3.5 ± 2.2 for PD98059-treated cultures (n = 6). Immunity 1997 7, 609-618DOI: (10.1016/S1074-7613(00)80382-9)

Figure 7 ERK Is Required for Maturation from DP to CD4 SP E16 thymi were cultured for 5 days in the presence or absence of 30 μM PD98059 MEK inhibitor. Thymocytes were triple stained with anti-CD4-PE, anti-CD8-Tricolor, and anti-CD3-FITC. Numbers represent the percentage of live cells in the indicated quadrant. Histograms represent CD3 expression of total or SP thymocytes. Dashed lines, thymi cultured in medium alone; solid lines, thymi cultured with 30 μM PD98059. The average cell recovery (× 10−5) was 6.4 ± 3.7 for controls (n = 5) and 11.1 ± 3.5 for PD98059-treated cultures (n = 7). Immunity 1997 7, 609-618DOI: (10.1016/S1074-7613(00)80382-9)